Andrew Carr

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Pharmaceutical Crystallography. Top assignees: R.j. Reynolds Tobacco Company, Metro International Biotech, LLC, Neurocrine Biosciences, Inc.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Carr. Retrieved from https://idiyas.com/inventor/andrew-carr-rytzefa1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 3)

% Patents Active = 86.4

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 128(Granted Patents)

Location History:

Little Chesterford, GB (2011)
Hinxton, GB (2019 - 2021)
Cambridge, GB (2010 - 2024)

Company Filing History:

8 out of 975

R.j. Reynolds Tobacco Company

patents

5 out of 21

Metro International Biotech, LLC

patents

4 out of 123

Neurocrine Biosciences, Inc.

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

Nicotine Salts

Co-Crystals

Beta-Nicotinamide

Polymorphs

Valbenazine

Cysteine Protease Inhibitors

Substituted Aniline

Crystalline Forms

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454517 - Nicotine salts, co-crystals, and salt co-crystal complexes (2025-10-28),

2. 12391721 - Crystal forms of beta-nicotinamide mononucleotide (2025-08-19),

3. 12077518 - Nicotine salts, co-crystals, and salt co-crystal complexes (2024-09-03),

4. 11136305 - Nicotine salts, co-crystals, and salt co-crystal complexes (2021-10-05),

5. 11059847 - Crystal forms of β-nicotinamide mononucleotide (2021-07-13),

6. 10865192 - Nicotine salts, co-crystals, and salt co-crystal complexes (2020-12-15),

7. 10851104 - Valbenazine salts and polymorphs thereof (2020-12-01),

8. 10851103 - Valbenazine salts and polymorphs thereof (2020-12-01),

9. 10844058 - Valbenazine salts and polymorphs thereof (2020-11-24),

10. 10556880 - Nicotine salts, co-crystals, and salt co-crystal complexes (2020-02-11),

11. 10464917 - Nicotine salts, co-crystals, and salt co-crystal complexes (2019-11-05),

12. 10392416 - Crystal forms of beta-nicotinamide mononucleotide (2019-08-27),

13. 10392415 - Crystal forms of β-nicotinamide mononucleotide (2019-08-27),

14. 10233208 - Crystal forms of beta-nicotinamide mononucleotide (2019-03-19),

15. 10065952 - Valbenazine salts and polymorphs thereof (2018-09-04),

Title: Andrew Carr - Innovative Inventor from Cambridge, GB

Introduction: Andrew Carr is a renowned inventor based in Cambridge, GB, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Andrew Carr holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in the industry, Andrew Carr has led numerous successful projects that have revolutionized the way we approach modern challenges. His commitment to pushing the boundaries of innovation has earned him recognition worldwide.

Collaborations: Throughout his career, Andrew Carr has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Andrew Carr's passion for innovation and his relentless drive to create a positive impact on society make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.